Improving Cancer Immunotherapy Outcomes Using Biomaterials
- 15 April 2020
- journal article
- review article
- Published by Wiley in Angewandte Chemie
- Vol. 132 (40) , 17484-17495
Abstract
Immunotherapy has made great strides in improving clinical outcomes in cancer treatment. However, few patients exhibit adequate response rates for key outcome measures and desired long‐term responses, and they often suffer systemic side effects due to the dynamic nature of the immune system. This has motivated a search for alternative strategies to improve unsatisfactory immunotherapeutic outcomes. In recent years, biomaterial‐assisted immunotherapy has shown promise in cancer treatment with improved therapeutic efficacy and reduced side effects. These biomaterials have illuminated fundamental mechanisms underlying the immunoediting process, while greatly improving the efficacy of chimeric antigen receptor (CAR) T‐cell therapy, cancer vaccine therapy, and immune checkpoint blockade therapy. This Minireview discusses recent advances in engineered biomaterials that address limitations associated with conventional cancer immunotherapies.Keywords
Funding Information
- National Research Foundation Singapore (NRF-NRFI05-2019-0003)
This publication has 152 references indexed in Scilit:
- Controlling upconversion nanocrystals for emerging applicationsNature Nanotechnology, 2015
- Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based ImmunotherapyACS Nano, 2015
- Biopolymer implants enhance the efficacy of adoptive T-cell therapyNature Biotechnology, 2014
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacyNature Biotechnology, 2014
- Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti‐CTLA‐4 Therapy to Inhibit Cancer MetastasisAdvanced Materials, 2014
- Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulationBiomaterials, 2014
- Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug DeliveryNano Letters, 2014
- Structure-based programming of lymph-node targeting in molecular vaccinesNature, 2014
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- Therapeutic cell engineering with surface-conjugated synthetic nanoparticlesNature Medicine, 2010